Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 19, 2021

SELL
$14.84 - $22.23 $183,125 - $274,318
-12,340 Closed
0 $0
Q4 2020

Feb 24, 2021

SELL
$9.4 - $16.7 $88,679 - $157,547
-9,434 Reduced 43.33%
12,340 $187,000
Q3 2020

Dec 11, 2020

BUY
$10.54 - $24.96 $76,562 - $181,309
7,264 Added 50.06%
21,774 $229,000
Q2 2020

Aug 07, 2020

BUY
$21.87 - $33.11 $317,333 - $480,426
14,510 New
14,510 $355,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $211M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.